[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bridgebio Pharma Inc (BBIO)

Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bridgebio Pharma Inc 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 USA

www.bridgebio.com Employees: 839 P: 650-391-9740

Sector:

Medical

Description:

BridgeBio Pharma Inc. is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio Pharma Inc. is based in PALO ALTO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 16,330,900
Enterprise Value, $K 17,612,680
Shares Outstanding, K 195,486
Float, K 167,668
% Float 85.77%
Short Interest, K 25,751
Short Float 13.17%
Days to Cover 5.38
Short Volume Ratio 0.66
% of Insider Shareholders 14.23%
% of Institutional Shareholders 99.85%

Financials:

Annual Sales, $ 502,080 K
Annual Net Income, $ -724,930 K
Last Quarter Sales, $ 194,520 K
Last Quarter Net Income, $ -164,040 K
EBIT, $ -525,000 K
EBITDA, $ -513,600 K

Growth:

1-Year Return 80.25%
3-Year Return 167.33%
5-Year Return 363.25%
5-Year Revenue Growth 5,985.82%
5-Year Earnings Growth 0.53%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.84 on 05/07/26
Next Earnings Date 08/04/26 [--]
Earnings Per Share ttm -3.74
EPS Growth vs. Prev Qtr 16.00%
EPS Growth vs. Prev Year 4.55%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 3-1 on 12/27/21

BBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -65.81%
Profit Margin % -144.39%
Debt/Equity -0.85
Price/Sales 33.31
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -11.58
Interest Coverage -3.11
60-Month Beta 0.95
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.